The U.S. Food & Drug Administration (FDA) has announced the voluntary recall of a sinus nasal wash bottle system following a confirmed test result of microbial contamination.
If you feel like your nose has been dripping all winter long, you’re not alone. Nasal congestion is one of the most frequent ...
9h
The Healthy on MSNOTC Medication Mistakes: Doctors Advise You To Avoid Doing TheseEvery medication, whether OTC or by prescription, needs to be taken seriously,” says Stacy Jean Willner, DO, a cardiologist ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
My first experience of hay fever was when I was revising for my A-level exams over thirty years ago,” Catherine said. “That ...
The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the ...
Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded ...
The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...
The FDA reviews drug approval decisions that are expected in March 2025. The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled ...
Many recalls come as a result of product mislabeling, safety issues or contamination. Here are five recalls in particular ...
Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.
Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results